Vesting of Performance Rights and Appendix 2A

Imagion Biosystems has today advised that 2,500,000 performance rights have vested and were issued as ordinary shares to Executive Chairman and CEO, Bob Proulx today, Thursday 10 September, under the terms of Mr Proulx’s employment agreement.

The attached ASX announcements in relation to issue of shares to Mr Proulx as a result of vesting of performance rights were released to market.

Vesting of Performance Rights

Appendix 2A